⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27352675 | 0.89 | — | — | |
| SCHEMBL28164207 | 0.88 | — | — | |
| Fluorene SCHEMBL28168271 | 0.88 | MAOA (0.34) | — | |
| SCHEMBL17097355 | 0.81 | — | — | |
| SCHEMBL28237716 | 0.80 | — | — | |
| SCHEMBL2910159 | 0.73 | — | — | |
| SCHEMBL12492449 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL7428077 | 0.73 | — | — | |
| SCHEMBL4574223 | 0.72 | — | — | |
| SCHEMBL13816171 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 680 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026042047-A1 | COMPOSITIONS AND ARTICLES COMPRISING REVERSIBLE COMPLEXES OF CROSSLINKED CARRAGEENAN | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2026-02-26 | — | — | WO | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| US-20250034080-A1 | CATIONIC LIPID CONTAINING SIDE-CHAIN FUNCTIONAL GROUPS AND APPLICATION THEREOF | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2025-01-30 | — | — | US | claimed |
| EP-4458805-A1 | CATIONIC LIPID CONTAINING FUNCTIONAL GROUP ON SIDE CHAIN, AND USE THEREOF | Xiamen Sinopeg Biotech Co., Ltd. (CN) | 2024-11-06 | — | — | EP | claimed |
| CN-117377651-A | Cationic lipid with side chain containing functional groups and application thereof | 厦门赛诺邦格生物科技股份有限公司 | 2024-01-09 | — | — | CN | claimed |
| CN-116284046-A | Ballon Sha Wei derivative, and preparation method and application thereof | 山东新华制药股份有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-111362810-B | Compound containing dibenzosuberene and application thereof in organic electroluminescent device | 江苏三月科技股份有限公司 | 2023-04-18 | — | — | CN | claimed |
| CN-115197080-A | Polyethylene glycol lipid and liposome modified by same, pharmaceutical composition containing liposome, preparation and application of pharmaceutical composition | 厦门赛诺邦格生物科技股份有限公司 | 2022-10-18 | — | — | CN | claimed |
| CN-115197079-A | Polyethylene glycol lipid and liposome modified by same, pharmaceutical composition containing liposome, preparation and application of pharmaceutical composition | 厦门赛诺邦格生物科技股份有限公司 | 2022-10-18 | — | — | CN | claimed |
| CN-115010915-A | Nitrogen branched nine-arm polyethylene glycol derivative, preparation method and biological related substance modified by nitrogen branched nine-arm polyethylene glycol derivative | 厦门赛诺邦格生物科技股份有限公司 | 2022-09-06 | — | — | CN | claimed |
| EP-1124553-A1 | NEW USE OF GLUTAMATE ANTAGONISTS FOR THE TREATMENT OF CANCER | Ikonomidou, Hrissanthi (DE) | 2001-08-22 | — | — | EP | claimed |
| US-6153193-A | A MICELLE COMPRISING AN ANTITUMOR AGENT, A POLYETHER BLOCK COPOLYMER AND A TARGETING MOLECULE COMPRISING A LIPOPHILIC HYDROCARBON MOIETY HAVING 3 TO ABOUT 41 CARBON ATOMS | SUPRATEK PHARMA INC. (CA) | 2000-11-28 | — | — | US | claimed |
| EP-1005651-A1 | METHODS OF IDENTIFYING BIOLOGICAL AGENT COMPOSITIONS | SUPRATEK PHARMA, INC. (CA) | 2000-06-07 | — | — | EP | claimed |
| EP-1002535-A1 | New use of glutamate antagonists for the treatment of cancer | Ikonomidou, Hrissanthi (DE) | 2000-05-24 | — | — | EP | claimed |
| WO-2000024395-A1 | NEW USE OF GLUTAMATE ANTAGONISTS FOR THE TREATMENT OF CANCER | IKONOMIDOU HRISSANTHI (DE) | 2000-05-04 | — | — | WO | claimed |
| WO-1999008112-A1 | METHODS OF IDENTIFYING BIOLOGICAL AGENT COMPOSITIONS | SUPRATEK PHARMA INC. (CA) | 1999-02-18 | — | — | WO | claimed |
| WO-1998041523-A1 | PROCESS FOR PREPARING DIBENZO-1-CARBOXAMIDO-1,4-AZABICYCLO(3.2.1.) OCTANES | NEUROGEN CORPORATION (US) | 1998-09-24 | — | — | WO | claimed |
| EP-0839026-A1 | POLYETHER BLOCK COPOLYMER MICELLAR COMPOSITIONS FOR TARGETING BIOLOGICAL AGENTS | SUPRATEK PHARMA, INC. (CA) | 1998-05-06 | — | — | EP | claimed |
| WO-1996040056-A1 | POLYETHER BLOCK COPOLYMER MICELLAR COMPOSITIONS FOR TARGETING BIOLOGICAL AGENTS | SUPRATEK PHARMA INC. (CA) | 1996-12-19 | — | — | WO | claimed |
| US-5506231-A | ADMINISTERING AN ANTAGONIST OF EXCITATORY AMINO ACIDS TO REDUCE CENTRAL NERVOUS SYSTEM DISORDER CAUSED BY HUMAN IMMUNODEFICIENCY VIRUS INFECTION | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 1996-04-09 | — | — | US | claimed |